CH Term (R4)
3.3.0-ci-build - ci-build
CH Term (R4)
3.3.0-ci-build - ci-build
CH Term (R4), published by HL7 Switzerland. This guide is not an authorized publication; it is the continuous build for version 3.3.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7ch/ch-term/ and changes regularly. See the Directory of published versions
| Active as of 2025-10-20 |
{
"resourceType" : "ConceptMap",
"id" : "ch-vacd-immunoglobulin-targetdiseases-cm",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ConceptMap ch-vacd-immunoglobulin-targetdiseases-cm</b></p><a name=\"ch-vacd-immunoglobulin-targetdiseases-cm\"> </a><a name=\"hcch-vacd-immunoglobulin-targetdiseases-cm\"> </a><p>Mapping from <a href=\"ValueSet-ch-vacd-swissmedic-immunoglobulin-vs.html\">CH VACD Swissmedic Authorized Immunoglobulin Codes</a> to <a href=\"ValueSet-ch-vacd-targetdiseasesandillnessesundergoneforimmunization-vs.html\">CH VACD Target disease and illnesses undergone for immunization</a></p><br/><p><b>Group 1 </b>Mapping from <a href=\"CodeSystem-ch-vacd-swissmedic-immunoglobulin-cs.html\">CH VACD Swissmedic Authorized Immunoglobulin Codes</a> to <a href=\"http://hl7.org/fhir/R4/codesystem-snomedct.html\">SNOMED CT (all versions)</a></p><table class=\"grid\"><tr><td colspan=\"2\"><b>Source Concept Details</b></td><td><b>Relationship</b></td><td colspan=\"2\"><b>Target Concept Details</b></td></tr><tr><td colspan=\"2\"><b>Codes</b> from <a href=\"CodeSystem-ch-vacd-swissmedic-immunoglobulin-cs.html\" title=\"http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-swissmedic-immunoglobulin-cs\">CH VACD Swissmedic Authorized Immunoglobulin Codes</a></td><td/><td colspan=\"2\"><b>Codes</b> from <a href=\"http://hl7.org/fhir/R4/codesystem-snomedct.html\" title=\"http://snomed.info/sct\">SNOMED CT (all versions)</a></td></tr><tr><td style=\"border-right-width: 0px\">00687-01</td><td style=\"border-left-width: 0px\">Berirab 2 ml, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">14168008</td><td style=\"border-left-width: 0px\">Rabies (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">00687-02</td><td style=\"border-left-width: 0px\">Berirab 5 ml, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">14168008</td><td style=\"border-left-width: 0px\">Rabies (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">69039-02</td><td style=\"border-left-width: 0px\">Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">55735004</td><td style=\"border-left-width: 0px\">Respiratory syncytial virus infection (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">69039-01</td><td style=\"border-left-width: 0px\">Beyfortus 50 mg/0.5 ml, solution injectable en seringue préremplie</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">55735004</td><td style=\"border-left-width: 0px\">Respiratory syncytial virus infection (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">68222-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Cutaquig 165 mg/ml, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">65992-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Cuvitru 200 mg/ml, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">00506-02</td><td style=\"border-left-width: 0px\">Cytotect CP Biotest, Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">28944009</td><td style=\"border-left-width: 0px\">Infection caused by Cytomegalovirus (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">00701-02</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Gammanorm, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">16318001000119107</td><td style=\"border-left-width: 0px\">Hypogammaglobulinemia due to multiple myeloma (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">00668-01</td><td style=\"border-left-width: 0px\">Gamunex 10%, solution pour injection intraveineuse</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">14189004</td><td style=\"border-left-width: 0px\">Measles (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">00488-02</td><td style=\"border-left-width: 0px\">Hepatect CP, Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">66071002</td><td style=\"border-left-width: 0px\">Viral hepatitis type B (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">00674-01</td><td style=\"border-left-width: 0px\">Hepatitis-B-Immunglobulin Behring, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">66071002</td><td style=\"border-left-width: 0px\">Viral hepatitis type B (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">66410-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Hizentra 200mg/ml, Injektionslösung zur s.c. Anwendung, Fertigspritze</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">61547-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Hizentra, Injektionslösung zur s.c. Anwendung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">66684-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">HyQvia 100 mg/ml, Infusionslösung zur subkutanen Anwendung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">58157-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Ig Vena Kedrion 50 g/I, solution pour infusion</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">62913-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Intratect 10%, Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">57676-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Intratect 5%, Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">66332-03</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Iqymune 10g/100ml, Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">66332-04</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Iqymune 20g/200ml, Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">66332-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Iqymune 2g/20ml, Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">66332-02</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Iqymune 5g/50ml, Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">57469-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Kiovig, Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">60323-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Octagam 10 %, Lösung zur intravenösen Anwendung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">58314-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Privigen, Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">53609-02</td><td style=\"border-left-width: 0px\">Rhophylac 300, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">165746003</td><td style=\"border-left-width: 0px\">RhD negative (finding)</td></tr><tr><td style=\"border-right-width: 0px\">65695-02</td><td style=\"border-left-width: 0px\">Synagis 100 mg/1 ml, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">55735004</td><td style=\"border-left-width: 0px\">Respiratory syncytial virus infection (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">65695-01</td><td style=\"border-left-width: 0px\">Synagis 50 mg/0.5 ml, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">55735004</td><td style=\"border-left-width: 0px\">Respiratory syncytial virus infection (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">00673-02</td><td style=\"border-left-width: 0px\">Tetagam P, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">76902006</td><td style=\"border-left-width: 0px\">Tetanus (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">59374-01</td><td style=\"border-left-width: 0px\">Uman Big 180 UI/1 ml, solution pour injection intramusculaire</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">66071002</td><td style=\"border-left-width: 0px\">Viral hepatitis type B (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">59374-02</td><td style=\"border-left-width: 0px\">Uman Big 540 UI/3 ml, solution pour injection intramusculaire</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">66071002</td><td style=\"border-left-width: 0px\">Viral hepatitis type B (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">59451-01</td><td style=\"border-left-width: 0px\">Varitect CP, Lösung zur intravenösen Injektion</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">38907003</td><td style=\"border-left-width: 0px\">Varicella (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">59373-02</td><td style=\"border-left-width: 0px\">Venbig 2500 U.I/50 ml, poudre et solution pour injection intraveineuse</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">66071002</td><td style=\"border-left-width: 0px\">Viral hepatitis type B (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">59373-01</td><td style=\"border-left-width: 0px\">Venbig 500 U.I/10 ml, poudre et solution pour injection intraveineuse</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">66071002</td><td style=\"border-left-width: 0px\">Viral hepatitis type B (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">68471-01</td><td style=\"border-left-width: 0px\">Xevudy, Konzentrat zur Herstellung einer Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">840539006</td><td style=\"border-left-width: 0px\">Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">66344-01</td><td style=\"border-left-width: 0px\">Zinplava, Konzentrat zur Herstellung einer Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">56688005</td><td style=\"border-left-width: 0px\">Clostridial infection (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">61639-01</td><td style=\"border-left-width: 0px\">Zutectra, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">66071002</td><td style=\"border-left-width: 0px\">Viral hepatitis type B (disorder)</td></tr></table></div>"
},
"url" : "http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-immunoglobulin-targetdiseases-cm",
"version" : "3.3.0-ci-build",
"name" : "ImmunGlobulineToTargetDiseaseMapping",
"title" : "ImmunGlobuline To TargetDisease Mapping",
"status" : "active",
"experimental" : false,
"date" : "2025-10-20T19:09:01+00:00",
"publisher" : "HL7 Switzerland",
"contact" : [
{
"name" : "HL7 Switzerland",
"telecom" : [
{
"system" : "url",
"value" : "https://www.hl7.ch/"
}
]
},
{
"name" : "HL7 Switzerland",
"telecom" : [
{
"system" : "url",
"value" : "https://www.hl7.ch/",
"use" : "work"
}
]
}
],
"description" : "Mappings from ImmunGlobuline to TargetDisease according to the correcsponding valuesets",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "CH"
}
]
}
],
"copyright" : "This artefact includes content from SNOMED Clinical Terms® (SNOMED CT®) which is copyright of the International Health Terminology Standards Development Organisation (IHTSDO). Implementers of these artefacts must have the appropriate SNOMED CT Affiliate license - for more information contact http://www.snomed.org/snomed-ct/getsnomed-ct or info@snomed.org.",
"sourceUri" : "http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-swissmedic-immunoglobulin-vs",
"targetUri" : "http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-targetdiseasesandillnessesundergoneforimmunization-vs",
"group" : [
{
"source" : "http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-swissmedic-immunoglobulin-cs",
"target" : "http://snomed.info/sct",
"element" : [
{
"code" : "00687-01",
"display" : "Berirab 2 ml, Injektionslösung",
"target" : [
{
"code" : "14168008",
"display" : "Rabies (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "00687-02",
"display" : "Berirab 5 ml, Injektionslösung",
"target" : [
{
"code" : "14168008",
"display" : "Rabies (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "69039-02",
"display" : "Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie",
"target" : [
{
"code" : "55735004",
"display" : "Respiratory syncytial virus infection (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "69039-01",
"display" : "Beyfortus 50 mg/0.5 ml, solution injectable en seringue préremplie",
"target" : [
{
"code" : "55735004",
"display" : "Respiratory syncytial virus infection (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "68222-01",
"display" : "Cutaquig 165 mg/ml, Injektionslösung",
"target" : [
{
"code" : "58606001",
"display" : "Primary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
},
{
"code" : "33286000",
"display" : "Secondary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "65992-01",
"display" : "Cuvitru 200 mg/ml, Injektionslösung",
"target" : [
{
"code" : "58606001",
"display" : "Primary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
},
{
"code" : "33286000",
"display" : "Secondary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "00506-02",
"display" : "Cytotect CP Biotest, Infusionslösung",
"target" : [
{
"code" : "28944009",
"display" : "Infection caused by Cytomegalovirus (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "00701-02",
"display" : "Gammanorm, Injektionslösung",
"target" : [
{
"code" : "58606001",
"display" : "Primary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
},
{
"code" : "16318001000119107",
"display" : "Hypogammaglobulinemia due to multiple myeloma (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "00668-01",
"display" : "Gamunex 10%, solution pour injection intraveineuse",
"target" : [
{
"code" : "14189004",
"display" : "Measles (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "00488-02",
"display" : "Hepatect CP, Infusionslösung",
"target" : [
{
"code" : "66071002",
"display" : "Viral hepatitis type B (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "00674-01",
"display" : "Hepatitis-B-Immunglobulin Behring, Injektionslösung",
"target" : [
{
"code" : "66071002",
"display" : "Viral hepatitis type B (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "66410-01",
"display" : "Hizentra 200mg/ml, Injektionslösung zur s.c. Anwendung, Fertigspritze",
"target" : [
{
"code" : "58606001",
"display" : "Primary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
},
{
"code" : "33286000",
"display" : "Secondary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "61547-01",
"display" : "Hizentra, Injektionslösung zur s.c. Anwendung",
"target" : [
{
"code" : "58606001",
"display" : "Primary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
},
{
"code" : "33286000",
"display" : "Secondary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "66684-01",
"display" : "HyQvia 100 mg/ml, Infusionslösung zur subkutanen Anwendung",
"target" : [
{
"code" : "58606001",
"display" : "Primary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
},
{
"code" : "33286000",
"display" : "Secondary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "58157-01",
"display" : "Ig Vena Kedrion 50 g/I, solution pour infusion",
"target" : [
{
"code" : "58606001",
"display" : "Primary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
},
{
"code" : "33286000",
"display" : "Secondary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "62913-01",
"display" : "Intratect 10%, Infusionslösung",
"target" : [
{
"code" : "58606001",
"display" : "Primary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
},
{
"code" : "33286000",
"display" : "Secondary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "57676-01",
"display" : "Intratect 5%, Infusionslösung",
"target" : [
{
"code" : "58606001",
"display" : "Primary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
},
{
"code" : "33286000",
"display" : "Secondary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "66332-03",
"display" : "Iqymune 10g/100ml, Infusionslösung",
"target" : [
{
"code" : "58606001",
"display" : "Primary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
},
{
"code" : "33286000",
"display" : "Secondary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "66332-04",
"display" : "Iqymune 20g/200ml, Infusionslösung",
"target" : [
{
"code" : "58606001",
"display" : "Primary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
},
{
"code" : "33286000",
"display" : "Secondary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "66332-01",
"display" : "Iqymune 2g/20ml, Infusionslösung",
"target" : [
{
"code" : "58606001",
"display" : "Primary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
},
{
"code" : "33286000",
"display" : "Secondary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "66332-02",
"display" : "Iqymune 5g/50ml, Infusionslösung",
"target" : [
{
"code" : "58606001",
"display" : "Primary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
},
{
"code" : "33286000",
"display" : "Secondary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "57469-01",
"display" : "Kiovig, Infusionslösung",
"target" : [
{
"code" : "58606001",
"display" : "Primary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
},
{
"code" : "33286000",
"display" : "Secondary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "60323-01",
"display" : "Octagam 10 %, Lösung zur intravenösen Anwendung",
"target" : [
{
"code" : "58606001",
"display" : "Primary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
},
{
"code" : "33286000",
"display" : "Secondary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "58314-01",
"display" : "Privigen, Infusionslösung",
"target" : [
{
"code" : "58606001",
"display" : "Primary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
},
{
"code" : "33286000",
"display" : "Secondary immune deficiency disorder (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "53609-02",
"display" : "Rhophylac 300, Injektionslösung",
"target" : [
{
"code" : "165746003",
"display" : "RhD negative (finding)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "65695-02",
"display" : "Synagis 100 mg/1 ml, Injektionslösung",
"target" : [
{
"code" : "55735004",
"display" : "Respiratory syncytial virus infection (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "65695-01",
"display" : "Synagis 50 mg/0.5 ml, Injektionslösung",
"target" : [
{
"code" : "55735004",
"display" : "Respiratory syncytial virus infection (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "00673-02",
"display" : "Tetagam P, Injektionslösung",
"target" : [
{
"code" : "76902006",
"display" : "Tetanus (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "59374-01",
"display" : "Uman Big 180 UI/1 ml, solution pour injection intramusculaire",
"target" : [
{
"code" : "66071002",
"display" : "Viral hepatitis type B (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "59374-02",
"display" : "Uman Big 540 UI/3 ml, solution pour injection intramusculaire",
"target" : [
{
"code" : "66071002",
"display" : "Viral hepatitis type B (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "59451-01",
"display" : "Varitect CP, Lösung zur intravenösen Injektion",
"target" : [
{
"code" : "38907003",
"display" : "Varicella (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "59373-02",
"display" : "Venbig 2500 U.I/50 ml, poudre et solution pour injection intraveineuse",
"target" : [
{
"code" : "66071002",
"display" : "Viral hepatitis type B (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "59373-01",
"display" : "Venbig 500 U.I/10 ml, poudre et solution pour injection intraveineuse",
"target" : [
{
"code" : "66071002",
"display" : "Viral hepatitis type B (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "68471-01",
"display" : "Xevudy, Konzentrat zur Herstellung einer Infusionslösung",
"target" : [
{
"code" : "840539006",
"display" : "Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "66344-01",
"display" : "Zinplava, Konzentrat zur Herstellung einer Infusionslösung",
"target" : [
{
"code" : "56688005",
"display" : "Clostridial infection (disorder)",
"equivalence" : "relatedto"
}
]
},
{
"code" : "61639-01",
"display" : "Zutectra, Injektionslösung",
"target" : [
{
"code" : "66071002",
"display" : "Viral hepatitis type B (disorder)",
"equivalence" : "relatedto"
}
]
}
]
}
]
}